Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Analysis, Inspection and Laboratory
LeftNav
Assisted/Independent Living
LeftNav
Clinical and Nursing Equipment
LeftNav
Design and Manufacture of Medical Equipment
LeftNav
Diagnostics Equipment, Monitoring and Test
LeftNav
Education, Training and Professional Services
LeftNav
Health Education and Patient Management
LeftNav
Health Estates Management
LeftNav
Healthcare Support and Information Services
LeftNav
Hygiene and Infection Control
LeftNav
IT and Communications in Healthcare
LeftNav
Materials
LeftNav
Medical Device Technology
LeftNav
Research and Development
LeftNav
Safety and Security
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
News

Global Med releases cellular therapy software solution for tissue banks in the USA

Global Med Technologies : 09 July, 2008  (New Product)
Global Med Technologies has announced the immediate release in the USA of EdgeCell, a proven cellular therapy software solution for tissue banks, stem cell laboratories and cord blood banks.
EdgeCell, with an installed base in Europe, will provide US customers with an established cellular therapy product that has been meeting the needs of a variety of European customers.

EdgeCell is a state-of-the-art cellular therapy software solution for hospitals, surgery centers and health care facilities. EdgeCell fully tracks the procurement process including the medical history questionnaire; any required testing including specimen reception and infectious disease testing; product preparation including packaging, labelling and storage as well as crossmatching and distribution. Along with an extensive list of safety features, EdgeCell incorporates full traceability and generation of regulatory documentation.

The complex nature of tissue banks, stem cell laboratories and cord blood banks dictates that distinct business rules and parameters be tailored to each type of product. EdgeCell meets this need through its ability to configure and maintain distinct business rules and parameters for each type of product be it tissue (bone parts, whole bone, cells, valves, cornea, skin, and other tissues), stem cells or cord blood. Inlog has the ISO 9001:2000 and NSF/ISO 25051/12119 certification for EdgeCell and its other products assuring the highest level of quality regarding the design, testing and validation of the software, the documentation of the software and the quality of support and maintenance.

Raphael Bardonnet, MD, director of the BioBank in Paris, France, stated, 'BioBank required a software solution that could meet our evolving needs as we develop new technologies for the preparation and processing of our biologics. We looked to Inlog, one of the European leaders in blood transfusion and medical software, for our tissue banking needs. For us, it was the logical choice because of Inlog's high quality standards and the ease with which EdgeCell can be configured for the multiple tissue types that we procure and the unique processes we use to prepare, test, store and distribute.'

Dr Bardonnet went on to state, 'As our researchers continue to develop innovative methods to prepare our products, EdgeCell can be easily adapted, without custom software development, to fully track our new processes including equipment and ancillary products that were used. We have been very satisfied with the reliability and ease of use in the EdgeCell client server graphical software application.'

Thomas F Marcinek, president and chief operating officer of Global Med Technologies, stated, 'We are very proud to offer EdgeCell for sale in the United States. When we made the announcement at our annual User Group meeting, our customers were very excited to hear about the imminent availability of a proven cellular therapy solution with an established customer base. EdgeCell is a product of Global Med's recent acquisition of Inlog, a leading provider of medical technology solutions with customers at 700 sites in 15 European, African and Middle Eastern countries.'

Marcinek added, 'We know the need for software solutions such as EdgeCell is rapidly increasing as more hospitals enter the emerging tissue transplantation market. With a global target market of more than 10,000 hospitals and surgical centers, we see EdgeCell as a growth platform that will greatly enhance our domestic and international expansion. We are confident in this product and its ability to provide the quality transplant management software our customers and potential customers have been seeking. As a forerunner in this essential technology, we are poised to satisfy the growing demand for proven biologic transplant management systems and to grow our global presence as a provider of quality healthcare software solutions.'
Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   © 2012 ProHealthServiceZone.com
Netgains Logo